Estrogen receptors are located in important brain areas that integrate cardiovascular and hydroelectrolytic responses, including the subfornical organ (SFO), supraoptic (SON) and paraventricular (PVN) nuclei. The aim of this study was to evaluate the influence of estradiol on cardiovascular and neuroendocrine changes induced by hemorrhagic shock in ovariectomized rats. Female Wistar rats (220-280 g) were ovariectomized and treated for seven days with vehicle or estradiol cypionate (EC, 10 or 40 µg/kg, sc). On the 8 th day, animals were subjected to hemorrhage (1.5 ml/100 g for 1 minute). Hemorrhage induced acute hypotension and bradycardia in the OVX-oil group, but EC treatment inhibited these responses. We observed increases in plasma angiotensin II concentrations and decreases in plasma atrial natriuretic peptide levels after hemorrhage; EC treatment produced no effects on these responses. There were also 
INTRODUCTION
The precise regulation of body fluids is essential for the metabolic function of virtually all cells in the body. A variety of mechanisms are activated to maintain plasma osmolality and blood volume within a very narrow range of values (3) . For example, hypovolemia and/or hypotension induce vasopressin (AVP) and oxytocin (OT) release from the magnocellular neurons of the supraoptic (SON) and paraventricular (PVN) nuclei in the hypothalamus (3, 56) . It is estimated that a decrease of 10 to 20% in total blood volume induces the release of AVP in several species. This neurosecretory response is modulated by peripheral baroreceptors in the aortic arch and carotid sinus, cardiopulmonary volume receptors and angiotensin II (ANG II) (50, 65 ).
The precise role of estrogen in maintaining body fluid homeostasis is not yet fully understood (16) . Our group has previously reported that ANG II AT 1 receptors are involved in the regulation of water and hypertonic saline intake in ovariectomized (OVX) rats during the nocturnal period (37, 38) . In addition, several reports have suggested that estrogen has modulatory effects on cardiovascular function, as evidenced by the cardiovascular changes observed in postmenopausal women, OVX rats and, possibly, females of other species during senescence (12, 46) . These effects occur by estrogen's action on the renin-angiotensin, atrial natriuretic peptide (ANP) and other peptidergic systems (33) . Thus, it is plausible to assume that investigating the association between electrolyte and cardiovascular homeostasis and estrogen's mechanisms of action may help clarify the controversial cardioprotective effect of estrogen reported in experimental and clinical trials (11) .
In a recent review, Somponpun (2007) described possible mechanisms by which estrogen regulates electrolyte homeostasis, focusing on AVP and OT (61) . The fact that estrogen receptors (ER) are expressed in key brain nuclei involved in body fluid maintenance strongly suggests a role for estrogen in hydroelectrolytic homeostasis; in rats, ERβ are expressed in magnocellular AVP and OT secretory neurons, and ERα are widely distributed in neurons in the basal forebrain nuclei (53, 55, 57, 58, 59, 60, 61) .
Despite the apparently controversial results in the literature, estrogen's effects on cardiovascular and hydroelectrolytic homeostasis seem to be at least partially due to its influence on AVP secretion (55) . In women, thirst and AVP secretion induced by osmotic stimuli are diminished during the luteal compared with the follicular phase of the menstrual cycle (67) . In post-menopausal women, Forsling et al. (1982) observed an increase in basal AVP plasma levels after estrogen therapy (24) . In animal models, Crofton et al. (1985) observed no changes in plasma AVP levels in OVX rats treated with estrogen, while Skowsky et al. (1979) observed an increase in AVP secretion during proestrus compared with diestrus in intact female rats and OVX rats treated with estrogen (14, 54) . However, Crofton et al. (1985) observed that estrogen plus progesterone reversed the OVX-induced increase in AVP release, while Peysner and Forsling (1990) observed a reduction in plasma AVP concentrations after OVX and either an increase (low dose) or reduction (high dose) in AVP levels after estrogen treatment (14, 45) .
Although the influence of OT on reproductive function is well established, knowledge of its effects on electrolyte balance and cardiovascular function is scarce. A positive correlation between estrogen and plasma OT concentrations in young women has been previously reported (2) . Furthermore, gonadal steroid hormones have been shown to be required for increases in OT mRNA expression in magnocellular neurons of the SON and PVN in rats subjected to osmotic stimulus (15) .
Hemorrhagic hypovolemia is a common clinical condition that occurs as a consequence of trauma, surgeries, gastrointestinal diseases and anticoagulant therapy (34) . Understanding the mechanisms involved in the control of homeostatic changes after hemorrhage is extremely important for the development of new therapeutic approaches. Because estrogen is closely related to neuroendocrine systems, integrating cardiovascular and hydroelectrolytic functions, the aim of this study was to evaluate the influence of estrogen on cardiovascular and neuroendocrine changes induced by hemorrhagic hypovolemia in OVX rats. Thus, we evaluated the effects of estradiol treatment on ANG II, ANP, AVP, OT and prolactin (PRL) secretion and activation of vasopressinergic and oxytocinergic neurons in the SON and PVN in OVX rats subjected to hemorrhage.
MATERIALS AND METHODS

Animals
Female Wistar rats (220-280 g) obtained from the Animal Facility of the campus of Ribeirao Preto, University of Sao Paulo, Brazil, were group-housed (four animals per cage) under controlled temperature and light conditions (23 ± 2 °C, lights on between 06:00 and 18:00) with free access to standard food pellets and tap water. All experiments were performed in the morning (between 07:00 and 11:00). 
Surgeries
All surgical procedures were performed under anesthesia induced by 2.5% 2,2,2-tribromoethanol (250 mg/kg, i.p., Sigma) and were followed by prophylactic doses of veterinary pentabiotic (Fort Dodge).
Ovariectomy and Estradiol Treatment
Female rats were subjected to bilateral ovariectomy (OVX) and randomly separated into groups treated with corn oil (OVX-oil) or estradiol cypionate (EC, Pfizer) at 10 (OVX-EC 10) or 40 (OVX-EC 40) µg/kg. Vehicle or EC administration (0.1 mL/rat, s.c.) started 24 h after OVX and was conducted once a day for 8 consecutive days between 7:00 and 10:00 h. The efficiency of the OVX procedure and estradiol treatment was confirmed by estradiol plasma concentration and a uterine index (uterus weight/body weight expressed as milligrams per 100 g of body weight) after 8 days of treatment.
We observed a significant increase in plasma estradiol concentrations in a dosedependent manner in the OVX-EC 10 and OVX-EC 40 groups compared with the OVX-oil group (72.2 ± 6.1 and 201.4 ± 30.4 vs. 21.6 ± 2.0 pg/mL, N = 8/10/7, respectively, p<0.05). We also verified a significant increase in the uterine index in the OVX-EC 10 and OVX-EC 40 groups when compared with the OVX-oil group (216 ± 9.0 and 367.0 ± 23.5 vs. 53.5 ± 6.5 mg/100 g body weight, N = 15/14/15, respectively, p<0.001) (37, 38) . These results confirm the efficiency of estrogen treatment in reestablishing estradiol plasma levels after ovariectomy and the trophic uterine index.
Additionally, published data in the literature support the evidence that 10 µg/kg of estradiol cipyonate is sufficient for estrogen replacement as a physiological dose (similar to estradiol concentrations found in proestrus rats) and 40 µg/kg as a supra-physiological dose (62) . However, due to different doses of estradiol used, several reports have found diverse responses mediated by this steroid (24, 27, 45) . For this reason, we chose two different doses of estradiol in this study.
Femoral artery cannulation
For the hemorrhage procedure and cardiovascular recordings, animals were subjected to right femoral artery cannulation; a polyethylene cannula (PE-10 connected to PE-50, Intramedic; Becton Dickinson, Sparks, MD) was inserted and then externalized in the dorsal cervical region. Soon after, the cannula was flushed with isotonic saline containing heparin (100 IU/ml, Liquemine, Roche) to prevent obstruction. Animals were allowed to recover for 24 h before the experimental procedure.
Hemorrhage
Fifteen minutes prior to the hemorrhage procedure, isotonic saline containing heparin (150 IU in 150 µl) was administered through the arterial catheter to prevent blood clotting during blood removal. The hemorrhage procedure was achieved by blood removal through the arterial catheter (15 ml/kg body weight, corresponding to ~ 25% of total blood volume) for 1 min. False hemorrhage was performed using the same protocols without blood withdrawal.
Cardiovascular recordings
For mean arterial pressure (MAP, mmHg) and heart rate (HR, bpm) assessment, the arterial catheter was connected to a pressure transducer (P23Gb; Statham Instruments, Hato Hey, Puerto Rico) and data acquisition system (Windaq/200, Dataq Instruments, Hohi, USA). After 20 min of adaptation, baseline data were collected for 10 min, and the blood withdrawal was then initiated, followed by monitoring of hemodynamic changes for 30 min. The data represent several data points from a continuous recording.
Plasma hormone determination
For plasma hormone measurements, animals were decapitated, and the blood was collected from the trunk at 0 (baseline) and intra-and inter-assay coefficients of variation were 20 pg/mL, 1.4 e 27.1% for estradiol; 0.5 pg/mL, 10.9 e 17.1% for ANG II; 0.7 pg/mL, 4.8 and 10.0% for ANP; 0.8 pg/mL, 7.7 e 11.9% for AVP; 0.9 pg/mL, 7.0 e 12.6% to OT; and 0.9 ng/mL, 5.2 and 11.8% for PRL.
Perfusion, tissue preparation and immunohistochemistry
Ninety minutes after hemorrhage induction, the anesthetized animals were transcardially perfused with 200 ml of isotonic saline containing heparin (50 UI/L) followed by 400 ml of 4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7. The avidin-biotin-peroxidase complex was used for staining (ABC, Vector Laboratories Inc.), followed by 0.5% diaminobenzidine hydrochloride (DAB, Sigma Chemical Co., St. Louis, MO, USA) intensified with 5% cobalt chloride and 1% nickel ammonium sulfate, which labels the cell nuclei black.
For double labeling, after concluding the Fos protocol described above, sections were incubated with anti-OT or anti-AVP (both produced in rabbits, 1:10,000, Peninsula, San Carlos, CA, USA) for 48 h at 4 °C. Thereafter, sections were washed and subjected to the protocol described for Fos labeling, using appropriate secondary biotinylated antibodies followed by the avidin-biotin-peroxidase complex. The brown cytoplasmatic color was detected using a non-intensified DAB solution. Finally, the sections were mounted on gelatinized slides, air-dried overnight, dehydrated, cleared in xylene and placed under a coverslip with Ethelan (New Jersey, USA).
Immuno-stained cells were quantified using a Leica microscope equipped with a DC 200 Leica digital camera and coupled to a computer using Leica Application Suite 
STATISTICAL ANALYSIS
Results are expressed as means ± error (SEM). For statistical purposes, estradiol results below the detection limit of the assay were assigned the value of the detection limit. Statistical analyses were conducted using one-way or two-way ANOVA (factors: time or hemorrhage and treatment) followed by the Bonferroni post-test. The level of significance was set at p<0.05.
EXPERIMENTAL PROTOCOLS
Protocol 1 -Effects of estradiol on MAP and HR in OVX rats submitted to hemorrhage.
Animals were connected to the acquisition system, and after 20 min of adaptation, baseline parameters were measured for 10 min. Then, blood withdrawal was performed, animals were reconnected to the system, and recording of the cardiovascular parameters resumed. Our results show the values of MAP and HR at 0 (baseline), 5, 15 and 30 min after hemorrhage induction.
Protocol 2 -Effects of estradiol on hemorrhage-induced hormone secretion in OVX rats.
Blood collected during hemorrhage induction (basal) and by decapitation (5, 15 or 30 min after hemorrhage) was used for radioimmunoassay measurements of ANG II, ANP, AVP, OT and PRL plasma levels.
Protocol 3 -Effects of estradiol on SFO, SON and PVN neuronal activation in
OVX rats submitted to hemorrhage. 
RESULTS
Protocol 1 -Effects of estradiol on MAP and HR in OVX rats subjected to hemorrhage.
Basal MAP was similar among the OVX-oil (110.2 ± 2.4 mmHg), OVX-EC 10 
DISCUSSION
In the present report, we observed that blood withdrawal reduced MAP and HR only at 5 min in the OVX-oil group. Hypotension induced by mild to moderate hemorrhage is usually accompanied by a tachycardic reflex response (29) ; however, we used moderate to severe hemorrhage in the present study, which is known to produce a bradycardic response as a consequence of the vasovagal reflex, i.e., an acute central hypovolemia with a consequent parasympathetic activation (1, 20, 40, 48) . The bradycardic reflex induced by parasympathetic activation is likely to involve activation of the periaqueductal gray substance and serotoninergic system that send inhibitory projections to the rostral ventrolateral medulla (RVLM), a crucial area implicated in the generation and modulation of sympathetic activity to the cardiovascular system (7, 9, 49, 51).
We observed an inhibition of the hypotension and bradycardic responses induced by hemorrhage in OVX-EC rats compared with the OVX-oil group. The sex steroid hormones are required for changes in baroreflex sensitivity, as shown by the changes that occur in the cardiovagal baroreflex sensitivity and renal sympathetic nerve activity during the estrous cycle of female rats that are abolished by OVX (25) .
Additionally, several studies have demonstrated the modulation of hypotensive responses by estrogen, although the data are controversial. Estrogen attenuated the hypotensive response after the administration of a β-adrenergic agonist (isoproterenol) but did not influence the tachycardic reflex response (32) . However, the recovery of MAP and HR after hemorrhage in Long Evans female rats was impaired by estrogen.
This did not occur in AVP-deficient animals (40) . Our results contrast with those obtained by these authors, possibly due to methodological differences in time and total blood volume removal. Women in the post-menopausal period and OVX rats present an increase in sympathetic activity with higher α 1 -adrenergic activation and peripheral vasoconstriction associated with a reduction in nitric oxide (NO) synthesis, possibly due to estrogen deficiency (68) . As a result, we suggest that both the lower basal HR in OVX-EC rats and attenuation of cardiovascular responses induced by hemorrhage in the OVX-EC group found in the present study could be a consequence of estrogen effects on autonomic activity.
Plasma ANP concentrations were reduced in all groups after blood withdrawal in accordance with well-established data in the literature demonstrating a decrease in its concentrations in response to hypovolemia (69) . However, despite previous demonstrations of the colocalization of estrogen and ANP receptors in cardiomyocytes and ANP secretion induced by estrogen perfusion in atrial cardiac cells, we did not observe an influence of estrogen on ANP secretion under basal or hemorrhagic conditions (4, 19) . Although estrogen was shown to modulate ANP secretion in response to osmolality changes and extracellular volume expansion (66) , it seems that the reduction of ANP release during hemorrhage is not influenced by estrogen treatment.
We also showed an important increase in plasma ANG II concentrations in all groups after the hemorrhage procedure. Systemic ANG II interacts with AT 1 receptors located in the vascular smooth muscle, leading to its contraction and consequently elevating arterial pressure, an important mechanism in reestablishing tissue perfusion after blood withdrawal (17) . Furthermore, circulating ANG II also acts on the central nervous system (CNS) structures devoid of blood-brain barrier, such as the SFO, contributing to the arterial pressure maintenance (17, 36) . Estradiol had no effect on the ANG II increase induced by hemorrhage.
It is possible that blood loss may not be the best experimental paradigm to evaluate the effects of estrogen on ANP secretion and RAS activity because hemorrhage is a potent stimulus for RAS and inhibits ANP secretion. Therefore, the potent neuroendocrine stimulation or inhibition may overcome the modulatory effects of estradiol on these systems.
Our results show an increase of Fos-immunoreactive neurons in the SFO after hemorrhage in OVX-EC-treated animals. Because there was no difference between plasma ANG II of OVX-oil and OVX-EC groups after hemorrhage and because it is well established that estrogen treatment reduces AT1 mRNA expression (18) (23) . The influence of estrogen on SFO neuronal activation could be exerted by direct action on the ERα in the SFO, decreasing the threshold activation of these neurons or acting through the above mentioned areas to increase stimulatory inputs to the SFO.
As expected, plasma AVP concentration was increased 5 min after blood withdrawal in all groups evaluated, and this response is mediated by baroreceptors, volume receptors and increased plasma ANG II concentrations (3). Interestingly, there was an increase in AVP secretion induced by hemorrhage in the OVX-EC rats, which is in accordance with previous studies observing a similar estrogen effect in rats and women both in basal conditions and after an osmotic or hypovolemic stimulus (24, 27, 45, 54) .
Hypovolemia induced by hemorrhage increases AVP and OT plasma levels and the number of Fos positive magnocellular neurons in the PVN and SON (8, 52 ).
This response is likely modulated by estrogen because it changes the number of Foslabeled cells in these nuclei observed in response to a variety of stimuli (27, 31) . (1990) demonstrated that sympathetic nerve activity and HR during hemorrhage were consistently higher in diabetes insipidus rats compared with normal Long-Evans or AVP-treated rats both before and after vagotomy (44) . In addition, these authors show that vagotomy attenuated the inhibitory effect of AVP on the HR response but not renal sympathetic nerve activity following hemorrhage in the same experimental model of AVP-deficient animals. Taken together, these results suggest that AVP may play a major role in the cardiovascular adjustments following hemorrhage.
In the present report, we observed an increase in OT and AVP magnocellular neuronal activation, assessed by the number of neurons double labeled for Fos/OT and Fos/AVP and hormone plasma concentrations in response to hemorrhage. Previous studies have demonstrated that AVP and OT could present negative chronotropic effects mediated by cardiac V 1 receptors (13, 22) . However, the estrogen effect attenuating the bradycardic response seems not to be related to OT and AVP plasma concentrations because estrogen potentiated hormone secretion after hemorrhage.
We also report a potentiation of AVP magnocellular neuronal activation mediated by estrogen following hemorrhage. Previous reports have already shown estrogen effects on AVP secretion and SON neuronal activation in female rats subjected to hemorrhage. However, they did not demonstrate the neuronal phenotype involved in this response, which could be AVP-or OT-producing cells (27) . Because PVN and SON neurons express ERβ, the modulation exerted by estrogen on AVP magnocellular activity and AVP secretion could be produced by a direct effect on the hypothalamic In our study, we observed a significant increase in magnocellular oxytocinergic activation in the PVN and SON and a concomitant increase in plasma OT concentrations following blood withdrawal, as previously described in response to hypotension and/or hypovolemia (56) . In addition, we demonstrate an intense parvocellular oxytocinergic neuronal activation induced by hemorrhage, which could indicate some physiological role for OT release as a neurotransmitter in hypovolemia and/or hypotension conditions. Treatment with estrogen potentiated the effects of hemorrhage on the activation of OT magnocellular neurons in the PVN, which corresponded with an enhancement of OT secretion in OVX-EC rats. However, estrogen did not change the response induced by hemorrhage on the number of Fos/OT double-labeled cells in the parvocellular groups, suggesting that estrogen acts selectively on AVP parvocellular neurons from the PVN in hypovolemic hemorrhagic conditions.
The potent increase in AVP and OT secretion observed in response to an acute hemorrhage induced a simultaneous reduction of hormone content in the SON and PVN under the same experimental conditions in male rats (47) . Previous reports have also demonstrated the increased secretion of prolactin after hemorrhage in male rats (35) .
Some studies have shown a positive correlation between stress intensity, OT hypothalamic synthesis and its release to systemic circulation, which was not found for AVP (21) . Furthermore, PRL, a stress-related hormone in rodents, was increased by hemorrhage in the present study. This evidence also supports the hypothesis that the observed increase in OT secretion following hemorrhage could be a non-specific stress response rather than an effect induced by hypotension or decreased circulating volume (41) . Thus, we suggest that the potentiating effect on AVP secretion and PVN and SON neuronal activation induced by estrogen may be not related to ERβ signaling. In a recent report, Grassi et al. (2010) demonstrated that the increase in AVP immunoreactivity in the PVN and SON induced by estrogen was not due to ERβ signaling, but it could be mediated by ERα (26) .
Because magnocellular neurons in the PVN and SON do not express ERα, this response (as in our experimental design) could be mediated by afferent ERα-expressing neurons from different areas, such as the SFO.
Estrogen has important genomic actions regulating the expression of several genes related to cellular excitability, including the synthesis of neurotransmitters, expression of ion channels and activation of intracellular cascades (10) . Therefore, we hypothesize that estrogen, through its genomic and non-genomic actions, can change the excitability threshold of circuits related to AVP and OT secretion. However, treatment with estrogen has been shown to decrease the expression of ERβ in the PVN (42) .
Moreover, ERβ is mainly expressed in AVP neurons, whereas less than 7-10% of ERβ reside in magnocellular OT cells in both male and female rats (58, 63) . However, we observed an estrogen-mediated potentiation of OT release and neuronal activity after hemorrhage compared with the oil-treated OVX group. In this context, Nomura et al. 
